IFPMA complaint operating procedure
The IFPMA Code of Practice Operating Procedure is an integral part of the Code, as it explains the precise steps taken by IFPMA when a complaint is received.
Any healthcare professional, company or member of the general public may file a complaint reporting a breach of any provision of the IFPMA Code.
The IFPMA Code establishes standards for the ethical promotion of pharmaceutical products to healthcare professionals, and outlines appropriate interactions with stakeholders such as patient organizations.
The IFPMA Code Operating Procedure provisions are delineated in Appendix I of the IFPMA Code of Practice (2012).
The IFPMA Code Complaint Procedure is a four step procedure:
The IFPMA Code applies to regions where no local codes or appropriate regulatory structures exist, or in cases where an IFPMA member company is not a member of a local/regional association.
In June 2013, IFPMA received an anonymous complaint from an employee of a pharmaceutical company relating to an alleged inappropriate sales incentive for prescription medicines in Jordan.
In May 2019, IFPMA received a complaint from an employee of a pharmaceutical company relating to alleged off-label promotion for a prescription medicine in Japan.
Upholding ethics and business integrity
IFPMA leads the way when it comes to maintaining and raising the ethical standards of the innovative pharmaceutical industry. These standards are the industry’s promise of trust, the most essential ingredient in innovation and patient welfare.